Skip to main content
main-content
Oncology

Treatment-related regret common in localized prostate cancer patients

Upset older man

Around 10% of men with localized prostate cancer experience treatment-related regret but this rate varies by treatment modality and is mediated by posttreatment functional outcomes and patient expectations, study findings indicate.

Rheumatology

​​​​​​​Telehealth diet, exercise program improves pain, function in knee osteoarthritis

Knee OA

Overweight or obese people with knee osteoarthritis may benefit from a diet- and exercise-focused telehealth intervention, which researchers have shown can improve pain and function over 6 months.

Headlines from across medwireNews

03-12-2021 | Rheumatology | News | Article

Targeting pain should be a priority in systemic sclerosis

Pain affects almost nine in every 10 people with systemic sclerosis, with multiple disease-related factors potentially contributing to pain intensity, researchers report.

03-12-2021 | Oncology | News | Article

ESMO malignant pleural mesothelioma guideline published

Click through for more information

03-12-2021 | Oncology | News | Article

Poziotinib shows potential for advanced NSCLC with HER2 exon 20 insertions

The tyrosine kinase inhibitor poziotinib has antitumor activity in heavily pretreated patients with advanced or metastatic non-small-cell lung cancer harboring HER2 exon 20 insertions, show data from the phase 2 ZENITH20 trial.

03-12-2021 | Diabetes | News | Article

Microvascular diabetes complications linked to adverse pregnancy outcomes

Among pregnant women with preexisting diabetes, those with nephropathy or retinopathy may be at increased risk for pregnancy complications, suggest findings from a systematic review and meta-analysis.

02-12-2021 | Rheumatology | News | Article

COVID-19: Meta-analysis suggests increased infection, mortality risk in people with RMDs

A meta-analysis carried out by the COVID-19 Global Rheumatology Alliance suggests that people with rheumatic and musculoskeletal diseases have a higher risk for SARS-CoV-2 infection and mortality than the general population.

02-12-2021 | Diabetes | News | Article

Pooled analysis supports diabetes prevention effect of dapagliflozin

A pooled analysis of the DAPA-HF and DAPA-CKD trials suggests that taking the SGLT2 inhibitor dapagliflozin reduced the participants’ risk for developing type 2 diabetes by around a third.

medwireNews is an established provider of authoritative, timely and independent medical news. We value your feedback and encourage you to contact us to make medwireNews.com your preferred medical news resource.

Meet the team

Image Credits